AES Cleanroom Technology appoints John Groth as chief revenue officer: Montgomeryville, Pa Wednesday, April 29, 2026, 14:30 Hrs [IST] AES Cleanroom Technology, a leading provider ...
TytoCare receives FDA De Novo classification for the first model of Tyto Insights for ENT Suite: New York Wednesday, April 29, 2026, 13:00 Hrs [IST] TytoCare, a virtual care compa ...
SRM Medical College Hospital and Research Centre Hosts “Illuminova ’26”: A futuristic UG research expo advancing healthcare with AI: Our Bureau, Bengaluru Wednesday, April 2 ...
Ferrotec introduces Ferrobeads DNA/RNA isolation kits for high-efficiency nucleic acid extraction: Livermore, California Wednesday, April 29, 2026, 13:30 Hrs [IST] Ferrotec (USA) ...
ISMOCD with AMC and Envu India helps unite India’s public health leadership to advance urban vector-borne disease control: Our Bureau, Bengaluru Wednesday, April 29, 2026, 12:15 ...
AbbVie seeks US FDA approval for Skyrizi subcutaneous induction for adults with moderately to severely active Crohn's disease: North Chicago, Illinois Wednesday, April 29, 2026, 1 ...
Thermo Fisher Scientific inks agreement to sell its microbiology business to Astorg for approximately $1.075 billion: Waltham, Massachusetts Wednesday, April 29, 2026, 11:00 Hrs [ ...
Athulya Senior Care inks MoU with SingHealth to advance care, training and research collaboration: Our Bureau, Bengaluru Wednesday, April 29, 2026, 11:45 Hrs [IST] Athulya Senior ...
Against this backdrop, the Assocham Pharma Summit & Excellence Awards 2026 will serve as a premier platform for dialogue, collaboration, and recognition. Bringing together policymakers, regulators, ...
Dr Reddy's Labs gets Health Canada approval for generic semaglutide injection: Our Bureau, Bengaluru Wednesday, April 29, 2026, 11:35 Hrs [IST] Dr Reddy’s Laboratories has recei ...
Boston Cell Standards enters into final phase of US FDA’s MDDT programme to qualify first-in-industry to standardize cancer diagnostic assays: Boston Wednesday, April 29, 2026, ...
GSK’s investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA PRIME designations to treat MASH: London, UK Wednesday, April 29, 2026, 09:00 Hrs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results